Search Within

Alexander Noor Shoushtari

  1. "Allison Betof Warner"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (10)
Groups
  1. Department of Medicine (25)
  2. Hematologic Malignancies, Division of (25)
  3. Hematology-Oncology Fellows (25)
  4. Melanoma Disease Management Team (25)
  5. Melanoma and Immunotherapeutics Service (25)
  6. Solid Tumor Oncology Division (25)

More Groups

People
  1. Allison Betof Warner (25)
  2. Michael Postow (19)
  3. Jedd Wolchok (17)
  4. Margaret Callahan (17)
  5. Paul Chapman (17)
  6. Katherine Panageas (15)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (3)
  5. 2021 (6)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (3)
  3. Annals of Oncology (1)
  4. Annals of Surgical Oncology (1)
  5. British Journal of Dermatology (1)
  6. Cancer Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (3)
  3. Oxford University Press (2)
  4. Wiley Blackwell (2)
  5. American Association for the Advancement of Science (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Programmed death ligand-1 PET imaging in patients with melanoma: A pilot study
    Journal Article

    Pandit-Taskar, N.; Mauguen, A.; Frosina, D.; Jungbluth, A.; Busam, K. J.; Lyashchenko, S.; Schwartz, J.; Momtaz, P.; Warner, A. B.; Smithy, J. W.; more...
    Melanoma Research (2025)

    Fulltext@MSK | Save
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
    Journal Article

    Hepner, A.; Versluis, J. M.; Wallace, R.; Allayous, C.; Brown, L. J.; Trojaniello, C.; Gerard, C. L.; Jansen, Y. J. L.; Bhave, P.; Neyns, B.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Kim, S. Y.; Schofield, E.; Postow, M. A.; Momtaz, P.; Warner, A. B.; Shoushtari, A. N.; Callahan, M. K.; Wolchok, J. D.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Neoadjuvant relatlimab and nivolumab in resectable melanoma
    Journal Article

    Amaria, R. N.; Postow, M.; Burton, E. M.; Tezlaff, M. T.; Ross, M. I.; Torres-Cabala, C.; Glitza, I. C.; Duan, F.; Milton, D. R.; Busam, K.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: An international multicentre observational study*
    Journal Article

    Bai, X.; Shoushtari, A. N.; Betof Warner, A.; Si, L.; Tang, B.; Cui, C.; Yang, X.; Wei, X.; Quach, H. T.; Cann, C. G.; more...
    British Journal of Dermatology (2022)

    Fulltext@MSK | Save
  • Adaptive dosing of nivolumab + ipilimumab immunotherapy based upon early, interim radiographic assessment in advanced melanoma (The ADAPT-IT study)
    Journal Article

    Postow, M. A.; Goldman, D. A.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; Smithy, J. W.; Naito, E.; Cugliari, M. K.; Raber, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save